Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer’s disease progression

We conducted a randomized placebo-controlled double-blind 24-week trial using Melissa officinalis (M. officinalis) extract richly containing rosmarinic acid (RA) on patients with mild dementia due to Alzheimer’s disease (AD) with the aim to examine the safety and tolerability (primary endpoint) of R...

詳細記述

保存先:
書誌詳細
出版年:Sci Rep
主要な著者: Noguchi-Shinohara, Moeko, Ono, Kenjiro, Hamaguchi, Tsuyoshi, Nagai, Toshitada, Kobayashi, Shoko, Komatsu, Junji, Samuraki-Yokohama, Miharu, Iwasa, Kazuo, Yokoyama, Kunihiko, Nakamura, Hiroyuki, Yamada, Masahito
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group UK 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7596544/
https://ncbi.nlm.nih.gov/pubmed/33122694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-73729-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料